These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 27371497)
1. Mephedrone and 3,4-methylenedioxy-methamphetamine: Comparative psychobiological effects as reported by recreational polydrug users. Jones L; Reed P; Parrott A J Psychopharmacol; 2016 Dec; 30(12):1313-1320. PubMed ID: 27371497 [TBL] [Abstract][Full Text] [Related]
2. Mephedrone and MDMA: A comparative review. Mead J; Parrott A Brain Res; 2020 May; 1735():146740. PubMed ID: 32087112 [TBL] [Abstract][Full Text] [Related]
3. Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat. Shortall SE; Macerola AE; Swaby RT; Jayson R; Korsah C; Pillidge KE; Wigmore PM; Ebling FJ; Richard Green A; Fone KC; King MV Eur Neuropsychopharmacol; 2013 Sep; 23(9):1085-95. PubMed ID: 23051939 [TBL] [Abstract][Full Text] [Related]
4. Substitutional potential of mephedrone: an analysis of the subjective effects. Kapitány-Fövény M; Kertész M; Winstock A; Deluca P; Corazza O; Farkas J; Zacher G; Urbán R; Demetrovics Z Hum Psychopharmacol; 2013 Jul; 28(4):308-16. PubMed ID: 23881878 [TBL] [Abstract][Full Text] [Related]
5. Acute behavioral effects of co-administration of mephedrone and MDMA in mice. Budzynska B; Michalak A; Frankowska M; Kaszubska K; Biała G Pharmacol Rep; 2017 Apr; 69(2):199-205. PubMed ID: 28073060 [TBL] [Abstract][Full Text] [Related]
6. Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users. Uosukainen H; Tacke U; Winstock AR Int J Drug Policy; 2015 Jan; 26(1):78-83. PubMed ID: 25107829 [TBL] [Abstract][Full Text] [Related]
7. Instability of the ecstasy market and a new kid on the block: mephedrone. Brunt TM; Poortman A; Niesink RJ; van den Brink W J Psychopharmacol; 2011 Nov; 25(11):1543-7. PubMed ID: 20826554 [TBL] [Abstract][Full Text] [Related]
8. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems. Parrott AC; Milani RM; Parmar R; Turner JD Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073 [TBL] [Abstract][Full Text] [Related]
9. [The phenomenon of drug change in the interviews with injecting drug users]. Rácz J; Csák R; Faragó R; Vadász V Psychiatr Hung; 2012; 27(1):29-47. PubMed ID: 22493147 [TBL] [Abstract][Full Text] [Related]
10. An observational study on the sub-acute effects of mephedrone on mood, cognition, sleep and physical problems in regular mephedrone users. Homman L; Seglert J; Morgan MJ Psychopharmacology (Berl); 2018 Sep; 235(9):2609-2618. PubMed ID: 29946859 [TBL] [Abstract][Full Text] [Related]
11. Intravenous self-administration of entactogen-class stimulants in male rats. Vandewater SA; Creehan KM; Taffe MA Neuropharmacology; 2015 Dec; 99():538-45. PubMed ID: 26302654 [TBL] [Abstract][Full Text] [Related]
12. Human Pharmacology of Mephedrone in Comparison with MDMA. Papaseit E; Pérez-Mañá C; Mateus JA; Pujadas M; Fonseca F; Torrens M; Olesti E; de la Torre R; Farré M Neuropsychopharmacology; 2016 Oct; 41(11):2704-13. PubMed ID: 27206266 [TBL] [Abstract][Full Text] [Related]
13. Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus. Angoa-Pérez M; Kane MJ; Herrera-Mundo N; Francescutti DM; Kuhn DM Life Sci; 2014 Feb; 97(1):31-6. PubMed ID: 23892197 [TBL] [Abstract][Full Text] [Related]
14. Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats. Motbey CP; Hunt GE; Bowen MT; Artiss S; McGregor IS Addict Biol; 2012 Mar; 17(2):409-22. PubMed ID: 21995495 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia. Shortall SE; Green AR; Swift KM; Fone KC; King MV Br J Pharmacol; 2013 Feb; 168(4):966-77. PubMed ID: 23043631 [TBL] [Abstract][Full Text] [Related]
16. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. Dargan PI; Albert S; Wood DM QJM; 2010 Nov; 103(11):875-9. PubMed ID: 20675396 [TBL] [Abstract][Full Text] [Related]
17. Mephedrone use among same-sex attracted young people in Sydney, Australia. Lea T; Reynolds R; De Wit J Drug Alcohol Rev; 2011 Jul; 30(4):438-40. PubMed ID: 21450044 [TBL] [Abstract][Full Text] [Related]
18. Caffeine alters the behavioural and body temperature responses to mephedrone without causing long-term neurotoxicity in rats. Shortall SE; Green AR; Fone KC; King MV J Psychopharmacol; 2016 Jul; 30(7):698-706. PubMed ID: 27257032 [TBL] [Abstract][Full Text] [Related]
19. Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation. Daumann J; Hensen G; Thimm B; Rezk M; Till B; Gouzoulis-Mayfrank E Psychopharmacology (Berl); 2004 May; 173(3-4):398-404. PubMed ID: 14722704 [TBL] [Abstract][Full Text] [Related]
20. "A costly turn on": patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors. Van Hout MC; Bingham T Int J Drug Policy; 2012 May; 23(3):188-97. PubMed ID: 22342322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]